Middle East & Africa Stem Cell Therapy Market Forecast to 2028 - Regional Analysis - by Type, Treatment, Application, and End User

List of Tables

The Middle East & Africa Stem Cell Therapy Market is expected to grow from US$ 53.25 million in 2022 to US$ 96.12 million by 2028. It is estimated to grow at a CAGR of 10.3% from 2022 to 2028.

Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management Drive Middle East & Africa Stem Cell Therapy Market

Stem cell therapy has been widely investigated across the world. Stem cells are mainly used to replace dying cells and reconstruct damaged tissues. Based on the results of extensive stem cell research conducted so far, many scientists have claimed that these cells could probably be utilized to generate cures and treatments for diseases such as cancer and cardiovascular disease. Newly developed stem cell therapies involve replacing disease-causing cells with stem cells. Many potential treatments involving stem cells are in different phases of clinical trials. Researchers are further investigating the use of stem cell therapy in treating autoimmune disorders. For example, stem cells can turn into the cells of damaged organs and are used in treating autoimmune diseases. Treatment is carried out using mesenchymal stem cells or fetal stem cells. Hematopoietic stem cells are currently used for treating more than 80 medicals conditions, including immune system diseases, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and cancer types such as leukemia and lymphoma.

Middle East & Africa Stem Cell Therapy Market Overview

Research and development for stem cells in UAE are gaining a rapid pace. Moreover, devising strategic policies and an increasing number of research partnerships & collaborations are projected to offer lucrative opportunities for the growth of the UAE stem cell therapy market during the forecast period. For instance, in 2019, Dubai Healthcare City announced an increase in stem cell banking services. The hospital and ReGen Medical Management entered into a partnership to offer a range of specialty regenerative services in the UAE. By September 2019, the hospital conducted around 600 successful stem cell therapy procedures.

Increasing awareness of benefits served by stem cell therapies and to offer these novel therapeutics for the treatment of chronic conditions, a significant number of investors and industry players are entering into the Middle East & Africa Stem Cell Therapy Market market. For instance, in September 2019, BRS Group announced a plan to open a stem cell research company in Abu Dhabi. Such aforementioned factors are responsible for influential growth of stem cell therapy in the UAE thereby dominating the overall market growth during the forecast period.

Middle East & Africa Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Stem Cell Therapy Market Segmentation

The Middle East & Africa Stem Cell Therapy Market is segmented into type, treatment, application, end user, and country.

Based on type, the Middle East & Africa Stem Cell Therapy Market is segmented into adult stem cell therapy, embryonic stem cell therapy, induced pluripotent stem cell therapy, and other stem cell therapy. In 2022, the adult stem cell therapy segment registered a largest share in the Middle East & Africa Stem Cell Therapy Market. The adult stem cell therapy segment is further segmented into hematopoietic stem cell therapy, umbilical cord stem cell therapy, neuronal stem cell therapy, and mesenchymal stem cell.

Based on treatment, the Middle East & Africa Stem Cell Therapy Market is bifurcated into allogeneic and autologous. In 2022, the allogeneic segment registered a larger share in the Middle East & Africa Stem Cell Therapy Market.

Based on application, the Middle East & Africa Stem Cell Therapy Market is segmented into musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications. In 2022, the musculoskeletal segment registered the largest share in the Middle East & Africa Stem Cell Therapy Market.

Based on end user, the Middle East & Africa Stem Cell Therapy Market is bifurcated into hospitals & specialty clinics and academic & research institutes. In 2022, the academic & research institutes segment registered a larger share in the Middle East & Africa Stem Cell Therapy Market.

Based on country, the Middle East & Africa Stem Cell Therapy Market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. In 2022, the UAE registered the largest share in the Middle East & Africa Stem Cell Therapy Market.

Lonza Group AG, Pluri Inc, Smith & Nephew Plc, and TiGenix NV (Takeda Pharmaceutical Company Limited) are the leading companies operating in the Middle East & Africa Stem Cell Therapy Market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA America stem cell therapy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA stem cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the stem cell therapy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00029078

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Middle East & Africa Stem Cell Therapy Market - By Type
- 1.3.2 Middle East & Africa Stem Cell Therapy Market - By Treatment
- 1.3.3 Middle East & Africa Stem Cell Therapy Market - By Application
- 1.3.4 Middle East & Africa Stem Cell Therapy Market - By End User
- 1.3.5 Middle East & Africa Stem Cell Therapy Market - By Country

2. Middle East & Africa Stem Cell Therapy Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Stem Cell Therapy Market- Market Landscape

4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Experts Opinion

5. Middle East & Africa Stem Cell Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
- 5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
- 5.2.1 High Cost of Approved Treatments
5.3 Market Opportunities
- 5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
- 5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis

6. Stem Cell Therapy Market - Middle East & Africa Analysis

6.1 Middle East & Africa Stem Cell Therapy Market Revenue Forecast and Analysis

7. Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 - by Type

7.1 Overview
7.2 Middle East & Africa Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
- 7.3.1 Overview
- 7.3.2 Adult Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Hematopoietic Stem Cell Therapy
  - 7.3.3.1 Overview
  - 7.3.3.2 Hematopoietic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Umbilical Cord Stem Cell Therapy
  - 7.3.4.1 Overview
  - 7.3.4.2 Umbilical Cord Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Neuronal Stem Cell Therapy
  - 7.3.5.1 Overview
  - 7.3.5.2 Neuronal Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Mesenchymal Stem Cell
  - 7.3.6.1 Overview
  - 7.3.6.2 Mesenchymal Stem Cell: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
- 7.4.1 Overview
- 7.4.2 Embryonic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
- 7.5.1 Overview
- 7.5.2 Induced Pluripotent Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
- 7.6.1 Overview
- 7.6.2 Other Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Treatment

8.1 Overview
8.2 Middle East & Africa Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
- 8.3.1 Overview
- 8.3.2 Allogeneic: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
- 8.4.1 Overview
- 8.4.2 Autologous: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Stem Cell Therapy Market Analysis and Forecasts to 2028 - by Application

9.1 Overview
9.2 Middle East & Africa Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
- 9.3.1 Overview
- 9.3.2 Musculoskeletal: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
- 9.4.1 Overview
- 9.4.2 Dermatology: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
- 9.5.1 Overview
- 9.5.2 Cardiology: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
- 9.6.1 Overview
- 9.6.2 Drug Discovery and Development: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
- 9.7.1 Overview
- 9.7.2 Other Applications: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 - by End User

10.1 Overview
10.2 Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
- 10.3.1 Overview
- 10.3.2 Academic & Research Institutes: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
- 10.4.1 Overview
- 10.4.2 Hospitals & Specialty Clinics: Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)

11. Middle East & Africa Stem Cell Therapy Market - Revenue and Forecast to 2028 - Country Analysis

11.1 Overview
- 11.1.1 Middle East & Africa: Stem Cell Therapy Market Share by Country - 2021 & 2028, (%)
  - 11.1.1.1 Saudi Arabia: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.1.1.1 Saudi Arabia: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.1.1.2 Saudi Arabia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
    - 11.1.1.1.2.1 Saudi Arabia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
    - 11.1.1.1.3 Saudi Arabia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
    - 11.1.1.1.4 Saudi Arabia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
    - 11.1.1.1.5 Saudi Arabia: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
  - 11.1.1.2 UAE: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.1.2.1 UAE: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.1.2.2 UAE: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
    - 11.1.1.2.2.1 UAE: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
    - 11.1.1.2.3 UAE: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
    - 11.1.1.2.4 UAE: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
    - 11.1.1.2.5 UAE: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
  - 11.1.1.3 South Africa: Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.1 South Africa: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.1.3.2 South Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
    - 11.1.1.3.2.1 South Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
    - 11.1.1.3.3 South Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
    - 11.1.1.3.4 South Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
    - 11.1.1.3.5 South Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)
  - 11.1.1.4 Rest of Middle East and Africa: Stem Cell Therapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.4.1 Rest of Middle East and Africa: Stem Cell Therapy Market - Revenue and Forecast to 2028 (USD Million)
    - 11.1.1.4.2 Rest of Middle East and Africa: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)
    - 11.1.1.4.2.1 Rest of Middle East and Africa: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)
    - 11.1.1.4.3 Rest of Middle East and Africa: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)
    - 11.1.1.4.4 Rest of Middle East and Africa: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)
    - 11.1.1.4.5 Rest of Middle East and Africa: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

12. Middle East & Africa Stem Cell Therapy Market-Industry Landscape

12.1 Overview
12.2 Organic Developments
- 12.2.1 Overview
12.3 Inorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 TiGenix NV (Takeda Pharmaceutical Company Limited)
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Lonza Group AG
- 13.2.1 Business Description
- 13.2.2 Products and Services
- 13.2.3 Financial Overview
- 13.2.4 SWOT Analysis
- 13.2.5 Key Developments
13.3 Pluri Inc
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Smith & Nephew Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms